Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-15-040238
Filing Date
2015-05-07
Accepted
2015-05-07 20:02:01
Documents
1
Period of Report
2015-05-04

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 7377
  Complete submission text file 0001209191-15-040238.txt   8976
Mailing Address C/O DOMAIN ASSOCIATES ONE PALO SQ PRINCETON NJ 08542
Business Address
WEBER ECKARD (Reporting) CIK: 0001279800 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35953 | Film No.: 15843676

Mailing Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-741-6625
Tobira Therapeutics, Inc. (Issuer) CIK: 0001311596 (see all company filings)

IRS No.: 030422069 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations